Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls
Modern Pathology2011Vol. 24(8), pp. 1090–1100
Citations Over TimeTop 10% of 2011 papers
Aude Lamy, France Blanchard, Florence Le Pessot, Richard Sesboüé, Frédéric Di Fiore, Jessie Bossut, Elodie Fiant, Thierry Frébourg, Jean‐Christophe Sabourin
Related Papers
- → Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer(2008)3,144 cited
- → Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer(2023)29 cited
- → KRAS Mutation Testing in Human Cancers: The Pathologist's Role in the Era of Personalized Medicine(2010)88 cited
- → A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer(2016)71 cited
- → KRAS mutations: Analytical considerations(2014)31 cited